113
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Permeation, stability and acute dermal irritation of miroestrol and deoxymiroestrol from Pueraria candollei var. mirifica crude extract loaded transdermal gels

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 967-977 | Received 23 Feb 2021, Accepted 10 Aug 2021, Published online: 23 Aug 2021

References

  • Aliyar H, Huber R, Loubert G, Schalau G. 2014. Efficient ibuprofen delivery from anhydrous semisolid formulation based on a novel cross-linked silicone polymer network: an in vitro and in vivo study. J Pharm Sci. 103(7):2005–2011.
  • Aliyar H, Schalau G. 2015. Recent developments in silicones for topical and transdermal drug delivery. Ther Deliv. 6(7):827–839.
  • Anusarnsoondhorn S. 1931. The remedy pamphlet of Kwao Krua tuber of Luang Anusornsuntarakromkarnpiset. Chiang Mai: Upatipongsa Press.
  • Aqil M, Ahad A, Sultana Y, Ali A. 2007. Status of terpenes as skin penetration enhancers. Drug Discov Today. 12(23–24):1061–1067.
  • Baboota S, Al-Azaki A, Kohli K, Ali J, Dixit N, Shakeel F. 2007. Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine. PDA J Pharm Sci Technol. 61(4):276–285.
  • Bali V, Ali M, Ali J. 2010. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces. 76(2):410–420.
  • Barry BW. 1991. Lipid-protein-partitioning theory of skin penetration enhancement. J Control Release. 15(3):237–248.
  • Bhatia KS, Gao S, Singh J. 1997. Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability through porcine skin. J Control Release. 47(1):81–89.
  • Brown MB, Hanpanitcharoen M, Martin GP. 2001. An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. Int J Pharm. 225(1–2):113–121.
  • Butani D, Yewale C, Misra A. 2014. Amphotericin B topical microemulsion: formulation, characterization and evaluation. Colloids Surf B Biointerfaces. 116:351–358.
  • Carroll N. 2010. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms. J Womens Health. 19(1):47–55.
  • Chansakaow S, Ishikawa T, Seki H, Sekine K, Okada M, Chaichantipyuth C. 2000. Identification of deoxymiroestrol as the actual rejuvenating principle of “Kwao Keur”, Pueraria mirifica. The known miroestrol may be an artifact. J Nat Prod. 63(2):173–175.
  • Cherdshewasart W, Panriansaen R, Picha P. 2007. Pretreatment with phytoestrogen-rich plant decreases breast tumor incidence and exhibits lower profile of mammary ERalpha and ERbeta. Maturitas. 58(2):174–181.
  • Cherdshewasart W, Sriwatcharakul S, Malaivijitnond S. 2008. Variance of estrogenic activity of the phytoestrogen-rich plant. Maturitas. 61(4):350–357.
  • Cherdshewasart W, Sutjit W, Pulcharoen K, Chulasiri K. 2009. The mutagenic and antimutagenic effects of the traditional phytoestrogen-rich herbs, Pueraria mirifica and Pueraria lobata. Braz J Med Biol Res. 42(9):816–823.
  • Chien YW. 1992. Novel drug delivery systems. 2nd ed. New York: Marcel Dekker, Transdermal drug delivery and delivery systems; p. 301–380.
  • Csizmazia E, Erős G, Berkesi O, Berkó S, Szabó-Révész P, Csányi E. 2011. Pénétration enhancer effect of sucrose laurate and Transcutol on ibuprofen. J Drug Deliv Sci Technol. 21(5):411–415.
  • Da Silva VV, Ropke CD, de Almeida RL, Miranda DV, Kera CZ, Rivelli DP, Sawada TCH, Barros SBM. 2005. Chemical stability and SPF determination of Pothomorphe umbellata extract gel and photostability of 4-nerolidylcathecol. Int J Pharm. 303(1–2):125–131.
  • Dua K, Pabreja K, Ramana M. 2010. Aceclofenac topical dosage forms: in vitro and in vivo characterization. Acta Pharm. 60(4):467–478.
  • El Gendy AM, Jun HW, Kassem AA. 2002. In vitro release studies of flurbiprofen from different topical formulations. Drug Dev Ind Pharm. 28(7):823–831.
  • Engelbrecht TN, Demé B, Dobner B, Neubert RHH. 2012. Study of the influence of the penetration enhancer isopropyl myristate on the nanostructure of Stratum corneum lipid model membranes using neutron diffraction and deuterium labelling. Skin Pharmacol Physiol. 25(4):200–207.
  • Femenía-Font A, Balaguer-Fernández C, Merino V, Rodilla V, López-Castellano A. 2005. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur J Pharm Biopharm. 61(1-2):50–55.
  • Fetih G. 2010. Meloxicam formulations for transdermal delivery: hydrogels versus organogels. J Drug Deliv Sci Technol. 20(6):451–456.
  • Forbes CJ, Lowry D, Geer L, Veazey RS, Shattock RJ, Klasse PJ, Mitchnick M, Goldman L, Doyle LA, Muldoon BCO, et al. 2011. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc. J Control Release. 156(2):161–169.
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2003. ICH harmonised tripartite guideline: stability testing of new drug substances and products Q1A(R2). Available from https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf/.
  • Jantharaprapap R, Stagni G. 2007. Effects of penetration enhancers on in vitro permeability of meloxicam gels. Int J Pharm. 343(1–2):26–33.
  • Jones HEM, Waynforth HB, Pope GSJ. 1961. The effect of miroestrol on vaginal cornification, pituitary function and pregnancy in the rat. J Endocrinol. 22(3):293–302.
  • Kaur D, Singh R. 2015. A novel approach: transdermal gel. Int J Pharm Res Rev. 4(10):41–50.
  • Lawrence MJ, Rees GD. 2000. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 45(1):89–121.
  • Leopold CS, Lippold BC. 1995. An attempt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with differential scanning calorimetry (DSC). J Pharm Pharmacol. 47(4):276–281.
  • Liu C-H, Chang F-Y, Hung D-K. 2011. Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants. Colloids Surf B Biointerfaces. 82(1):63–70.
  • Malaivijitnond S, Chansri K, Kijkuokul P, Urasopon N, Cherdshewasart W. 2006. Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herb. J Ethnopharmacol. 107(3):354–360.
  • Malladi R, Stahlman J, inventors. 2005. Besins Healthcare Luxembourg SARL Unimed Pharmaceuticals LLC, assignee. Oct 12. Testosterone gel and method of use. United States patent US 8,754,070B2.
  • Maske PP, Lokapure SG, Nimbalkar D, Malavi S, D'souza JI. 2013. In vitro determination of sun protection factor and chemical stability of Rosa kordesii extract gel. J Pharm Res. 7(6):520–524.
  • Matsumura A, Ghosh A, Pope GS, Darbre PD. 2005. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol. 94(5):431–443.
  • Megrab NA, Williams AC, Barry BW. 1995. Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation. J Control Release. 36(3):277–294.
  • Mishra R, Prabhavalkar KS, Bhatt LK. 2016. Preparation, optimization, and evaluation of zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery. J Liposome Res. 26(4):297–306.
  • Mitragotri S, Anissimov YG, Bunge AL, Frasch HF, Guy RH, Hadgraft J, Kasting GB, Lane ME, Roberts MS. 2011. Mathematical models of skin permeability: an overview. Int J Pharm. 418(1):115–129.
  • Naik A, Kalia YN, Guy RH. 2000. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today. 3(9):318–326.
  • Narang A, Delmarre D, Gao D. 2007. Stable drug encapsulation in micelles and microemulsions. Int J Pharm. 345(1–2):9–25.
  • OECD. 2002. OECD guideline for testing of chemicals, test no. 404: acute dermal irritation/corrosion. Available from: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg404.pdf.
  • Özsoy Y, Güngör S, Cevher E. 2004. Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations. Farmaco. 59(7):563–566.
  • Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen T, Urtti A. 2003. Microemulsions for topical delivery of estradiol. Int J Pharm. 254(2):99–107.
  • Prasanthi D, Lakshmi PK. 2013. Optimisation of transdermal gel formulations of tolterodine tartrate by experimental design. Turk J Pharm Sci. 10(2):273–286.
  • Rehman K, Zulfakar MH. 2014. Recent advances in gel technologies for topical and transdermal drug delivery. Drug Dev Ind Pharm. 40(4):433–440.
  • Rowe RC, Sheskey PJ, Quinn ME. 2009. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press.
  • Rozman B, Gosenca M, Gasperlin M, Padois K, Falson F. 2010. Dual influence of colloidal silica on skin deposition of vitamins C and E simultaneously incorporated in topical microemulsions. Drug Dev Ind Pharm. 36(7):852–860.
  • Shukla T, Upmanyu N, Agrawal M, Saraf S, Saraf S, Alexander A. 2018. Biomedical applications of microemulsion through dermal and transdermal route. Biomed Pharmacother. 108:1477–1494.
  • Sookvanichsilp N, Soonthornchareonnon N, Boonleang C. 2008. Estrogenic activity of the dichloromethane extract from Pueraria mirifica. Fitoterapia. 79(7-8):509–514.
  • Sucontphunt A, De-Eknamkul W, Nimmannit U, Dan Dimitrijevich S, Gracy RW. 2011. Protection of HT22 neuronal cells against glutamate toxicity mediated by the antioxidant activity of Pueraria candollei var. mirifica extracts. J Nat Med. 65(1):1–8.
  • Udomsin O, Juengwatanatrakul T, Yusakul G, Putalun W. 2015. Chromene stability: the most potent estrogenic compounds in White Kwao Krua (Pueraria candollei var mirifica) crude extract. J Funct Foods. 19(Part A):269–277.
  • Udomsuk L, Juengwatanatrakul T, Putalun W, Jarukamjorn K. 2012. Bimodal action of miroestrol and deoxymiroestrol, phytoestrogens from Pueraria candollei var. mirifica, on hepatic CYP2B9 and CYP1A2 expressions and antilipid peroxidation in mice. Nutr Res. 32(1):45–51.
  • Urasopon N, Hamada Y, Asaoka K, Cherdshewasart W, Malaivijitnond S. 2007. Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas. 56(3):322–331.
  • Urasopon N, Hamada Y, Cherdshewasart W, Malaivijitnond S. 2008. Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats. Maturitas. 59(2):137–148.
  • US EPA 2012. Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11. Washington (DC): United States Environmental Protection Agency.
  • Wang J, Li Z, Sun F, Tang S, Zhang S, Lv P, Li J, Cao X. 2017. Evaluation of dermal irritation and skin sensitization due to vitacoxib. Toxicol Rep. 4:287–290.
  • Wattanapitayakul SK, Chularojmontri L, Srichirat S. 2005. Effects of Pueraria mirifica on vascular function of ovariectomized rabbits. J Med Assoc Thai. 88(Suppl 1):S21–S29.
  • Williams AC, Barry BW. 2004. Penetration enhancers. Adv Drug Deliv Rev. 56(5):603–618.
  • You J, Meng S, Ning Y-K, Yang L-Q, Zhang XW, Wang H-N, Li J-J, Yin F-M, Liu J, Zhai Z-Y, et al. 2019. Development and application of an osthole microemulsion hydrogel for external drug evaluation. J Drug Deliv Sci Technol. 54:101331.
  • Yusakul G, Putalun W, Udomsin O, Juengwatanatrakul T, Chaichantipyuth C. 2011. Comparative analysis of the chemical constituents of two varieties of Pueraria candollei. Fitoterapia. 82(2):203–207.
  • Yusakul G, Udomsin O, Juengwatanatrakul T, Tanaka H, Chaichantipyuth C, Putalun W. 2013. High performance enzyme-linked immunosorbent assay for determination of miroestrol, a potent phytoestrogen from Pueraria candollei. Anal Chim Acta. 785:104–110.
  • Zhang X, Wu Y, Hong Y, Zhu X, Lin L, Lin Q. 2015. Preparation and evaluation of dl-praeruptorin A microemulsion based hydrogel for dermal delivery. Drug Deliv. 22(6):757–764.
  • Zidan AS, Kamal N, Alayoubi A, Seggel M, Ibrahim S, Rahman Z, Cruz CN, Ashraf M. 2017. Effect of isopropyl myristate on transdermal permeation of testosterone from carbopol gel. J Pharm Sci. 106(7):1805–1813.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.